SR ONE CAPITAL MANAGEMENT LLC 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 8:14 pm Sale |
2023-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR |
SR ONE CAPITAL MANAGEMENT LLC | 0 0.000% |
-272,885 (Position Closed) |
Filing |
| 2022-02-11 8:35 pm Purchase |
2021-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR |
SR ONE CAPITAL MANAGEMENT LLC | 272,885 16.900% |
272,885 (New Position) |
Filing |